Resource library

Veterinary Pharmaceutical Resources

Veterinary pharmaceutical resources for accepted materials, approved masters, executed lot records, testing, label reconciliation and accountable quality decisions.

Guides: 3 guides
Glossary: 3 glossary entries
Checklist: 9 buyer questions

Lot Packet & Reporting Handoff

US finished animal-drug lot evidence and approved-drug experience reporting, kept separate from feed, Type A article and biologics routes.

GuideVeterinary Drug Manufacturing Lot PacketA fictional lot from assigned master to label reconciliation, quality decision, complaint retrieval and reporting handoff.Read the guide
Glossary21 CFR 514.80Applicant and nonapplicant duties, 3-day field alerts versus 15-day alerts, follow-up and five-year records.Open
GuidePostapproval Change RecordsProduct-specific effects assessment, PAS and receipt-based CBE routes, MCSR planning and a worked retrieval exercise.Open
GlossaryLine ClearanceShared cleaning and packaging evidence, incomplete records, next-use decisions and a worked exception.Open

USDA Veterinary Biologics Serials

Licensed veterinary vaccines and other biologics follow USDA APHIS rules in 9 CFR, not FDA animal-drug law. Keep serial testing, release and reporting under that separate route.

Reference & Scope

This FDA overview distinguishes US animal-drug development from feed and other veterinary products. It is not a manufacturing-clause checklist or product approval; your regulatory team determines product and market applicability.

ReferenceFDA — Development & Approval ProcessOfficial animal-drug orientation with separate feed and biotechnology sections; not evidence that a product is approved.Read the reference

Software Pages

Compare the existing manufacturing and laboratory information with your own products, procedures and accountable quality responsibilities.

Evaluate the software

Work through these questions with your production and quality teams, then use them to plan an evaluation with your own records.

Animal-Drug Product and Market ScopeWhich animal drugs and markets are we evaluating, and who distinguishes their requirements from human drugs, medicated feed and veterinary biologics?

Accepted Materials and Lot IdentityWhat identity, supplier and testing evidence must our responsible team review before permitting an active or excipient lot to be used?

Authorize Materials for the Lot

Approved Master and Assigned RevisionCan we identify the master revision assigned to each product, strength and intended species without confusing the master with the executed batch?

Actual Execution and Lot EvidenceCan we reconstruct actual material lots, quantities, signed steps and corrections for one batch against its assigned master?

Cleaning and Changeover ReviewWhich cleaning and line-clearance checks do our own procedures require between products, and who reviews incomplete or exceptional records?

Required Tests and Pending EvidenceWhich tests apply to our product, who owns methods and results, and how do pending results stay distinct from completed and reviewed evidence?

Packaging and Label ReconciliationCan we reconcile issued, used, returned and rejected packaging and labels, including the applicable product, strength, species and lot details?

Label Issuance and Reconciliation

Accountable Quality DecisionWho reviews deviations and required evidence before recording batch disposition, including any separate customer or market responsibility?

Deviations and the Quality-Unit Decision

Traceability and System HandoversCan we connect a shipped lot or complaint to its executed record and contributing materials, and who tests reconciliation across our systems?

The existing operations guide remains email-gated. Review its product, market and system scope with your responsible team; printing is available in the reader. Open the existing guide offer.

Explore the workflow

The illustrated five-step workflow follows the assigned approved master, actual dispensing lots, cleaning and changeover checks, required test evidence, and label review with a human quality decision.

Explore the veterinary pharma workflow